Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles

Journal of Liposome Research

Volumn 19, Issue 2, 2009, Pages 91-98

  Manosroi, Aranya ^a,b   Khositsuntiwong, Narinthorn ^a   Gtz, Friedrich ^c   Werner, Rolf G ^d   Manosroi, Jiradej ^a,b  

^a Faculty of Pharmacy   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Elastic nanovesicles; Iontophoresis; Luciferase plasmid; Transdermal absorption

Indexed keywords

LIPOSOME; LUCIFERASE; LUCIFERASE PLASMID; NIOSOME; PLASMID DNA; UNCLASSIFIED DRUG; CATION; DIDODECYLDIMETHYLAMMONIUM; DNA; QUATERNARY AMMONIUM DERIVATIVE; SURFACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DERMIS; DIFFUSION; DRUG DELIVERY SYSTEM; ELASTICITY; EPIDERMIS; FREEZE DRYING; GEL ELECTROPHORESIS; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; STRATUM CORNEUM; ZETA POTENTIAL; ANIMAL; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; PLASMID; SPRAGUE DAWLEY RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CATIONS; DNA; FREEZE DRYING; LIPOSOMES; LUCIFERASES; MALE; PLASMIDS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURFACE-ACTIVE AGENTS;

EID: 67650665192     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100902731523     Document Type: Article

References (24)

1. Akdogan EK, Safari A. Electrostrictive properties of nanosize PbTiO3. IEEE TUFFC. 2000;47:881-885.
2. Aranda-Espinoza H, Chen Y, Dan N, Lubensky TC, Nelson P, Ramos L, et al. Electrostatic repulsion of positively charged vesicles and negatively charged objects. Science. 1999;285:394-397.
3. Cevc G, Blume G, Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. Journal of Controlled Release. 1997;45(3):211-226.
4. Choi MJ, Maibach HI. Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci. 2005;27:211-221.
5. Dayan N, Touitou E. Carriers for skin delivery of trihexylphenidyl HCL: ethosomes vs. liposomes. Biomaterials. 2000;21:1879-1885.
6. Evans RK, Xu Z, Bohannon KE, Wang B, Bruner MW, Volkin DB. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies. J Pharm Sci. 2000;89:76-87.
7. Hatanaka T, Shimoyama M, Sugibayashi K, Morimoto Y. Effect of vehicles on the skin permeability of drugs: polyethylene glycol 400-water and ethanol-water binary solvents. J Contr Rel. 1993;23:247-260.
8. Hoffman RM. Topical liposomes targeting of dyes, melanins, genes, and proteins selectivity to hair follicles. J Drug Targ. 1997;5:67-74.
9. Jain S, Jain P, Umamaheshwari RB, Jain NK. Drug Dev Ind Pharm. 2003;29:1013-1026.
10. Kikuchi H, Suzuki N, Ebihara K, Morita H, Ishii Y, Kikuchi A, Sugaya S, Serikawa T, Tanaka K. Gene delivery using liposome technology. J Control Release. 1999;62(1-2):269-277.
11. Knutson K, Krill SL, Zhang J. Solvent-mediated alterations of the stratum corneum. J Contr Rel. 1990;11:93-103.
12. Lasic D, Weiner N, Riaz M, Martin F. Liposomes. In: Lieberman A, Reiger M, Banker G, eds. Pharmaceutical Dosage Forms: Disperse Systems, 1998; Vol.3 (pp 43-86). New York: Marcel Dekker.
13. Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 2008a;360(1-2):156-163.
14. Manosroi A, Thathang K, Werner RG, Schubert R, Manosroi J. Stability of luciferase plasmid entrapped in cationic bilayer vesicles. Int J Pharm. 2008b;356(1-2):291-299.
15. Manosroi A, Thathang K, Werner RG, Schubert R, Peschka-Süss R, Manosroi J. Development of highly stable and low toxic cationic liposomes for gene therapy. Arzneim Forsch Drug Res. 2008c;58:485-492.
16. Manosroi A, Thathang K, Manosroi J, Werner RG, Schubert R, Peschka-Süss R. Effects of stabilizing lipids on gene expression of luciferase plasmid (pLuc) entrapped in cationic liposomes. J Liposom Res (in press 2008d).
17. Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin, silastic, and snake skin membrenes: the effects of ethanol/water co-solvent systems. Int J Pharm. 1995;116:101-112.
18. Plessis J, Egbaria K, Weiner N. Influence of formulation factors on the deposition of liposomal components into the different Strata of the Skin. J Soc Cosmet Chem. 1992;43:93-100.
19. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115-124. (Pubitemid 38239773)
20. Préat V, Dujardin N. Topical delivery of Nucleic acids in the Skin. STP Pharm Sciences. 2001;11(1):55-68.
21. Thathang K. Development of a Nanovesicular Formulation Entrapped with Plasmid DNA for an Efficient Gene Delivery System. 2008. Ph.D. thesis, Chiang Mai University, Thailand.
22. Touitou E, Dayan N, Bergelson l, Godin B, Eliaz M. Ethosomes-novel vesicular carriers: characterization and delivery properties. J Contr Rel. 2000;65:403-418.
23. Weiner N. Targeted follicular delivery of macromolecules via liposomes. Int J Pharm. 1998;162:29-38.
24. Yan G, Li SK, Higuchi WI. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J Contr Rel. 2005;110:141-150.